Publications by authors named "Jean Tredaniel"

Claim this Profile
S
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020.
Didier Debieuvre, Lionel Falchero, Olivier Molinier, Sébastien Couraud, Alexis Cortot, Jean Tredaniel

NEJM Evid· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study).
Emilie Cordina-Duverger, Shreeshti Uchai, Nastassia Tvardik, Régine Billmann, Diane Martin

Int J Environ Res Public Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Didier Debieuvre, Olivier Molinier, Lionel Falchero, Chrystèle Locher, Dorine Templement-Grangerat

Lancet Reg Health Eur· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
Assya Akli, Nicolas Girard, Vincent Fallet, Gaelle Rousseau-Bussac, Valérie Gounant

Target Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, Jean Domas, Philippe Girard

Lancet Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.
Nadia Guezour, Ghassen Soussi, Solenn Brosseau, Baptiste Abbar, Charles Naltet

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study).
Jennifer Rusmaully, Nastassia Tvardik, Diane Martin, Régine Billmann, Sylvie Cénée

BMC Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients.
Valérie Gounant, Michael Duruisseaux, Ghassen Soussi, Sylvie Van Hulst, Olivier Bylicki

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Sébastien Thureau, Vincent Marchesi, Marie-Hélène Vieillard, Lionel Perrier, Albert Lisbona, Jean Tredaniel

BMC Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Ludovic Fournel, Zherui Wu, Nicolas Stadler, Diane Damotte, Filippo Lococo

Cancer Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Camille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, Roger Lacave, Anaïs Pujals

Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
Alexandra Yannoutsos, Manon Fontaine, Alexandre Galloula, Diane Damotte, Gilles Chatellier

BMC Cardiovasc Disord· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management.
Mauro Loi, Antonio Mazzella, Audrey Mansuet-Lupo, Antonio Bobbio, Emelyne Canny

Ann Thorac Surg· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.
Zherui Wu, Ludovic Fournel, Nicolas Stadler, Jin Liu, Agnès Boullier

Cancer Lett· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Guy Meyer, Benjamin Besse, Hélène Doubre, Anaïs Charles-Nelson, Sandro Aquilanti, Jean Tredaniel

Eur Respir J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer.
Adrien Costantini, Jennifer Corny, Vincent Fallet, Sophie Renet, Sylvie Friard, Jean Tredaniel

ERJ Open Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.
Raphael Saffroy, Jean-François Morère, Nelly Bosselut, Pasquale F Innominato, Jocelyne Hamelin

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank.
Isabelle Stücker, Diane Martin, Monica Neri, Pierre Laurent-Puig, Hélène Blons

BMC Public Health· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge.
Daniel Satgé, Emmanuelle Kempf, Jean-Bernard Dubois, Motoi Nishi, Jean Trédaniel

Lung Cancer Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
Frédéric Fiteni, Dewi Vernerey, Franck Bonnetain, Fabien Vaylet, Hélène Sennélart

Eur J Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Sébastien Couraud, Pierre-Jean Souquet, Christophe Paris, Pascal Dô, Hélène Doubre

Eur Respir J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.
Benjamin Besse, Sylvestre Le Moulec, Julien Mazières, Hélène Senellart, Fabrice Barlesi

Clin Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.
Sébastien Couraud, Felipe Vaca-Paniagua, Stéphanie Villar, Javier Oliver, Tibor Schuster

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
Mohamad Younes, Zherui Wu, Sandra Dupouy, Audrey Mansuet Lupo, Najat Mourra

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenocarcinoma of the lung in Down syndrome: first clinical report.
Daniel Satgé, Sergio Salmeron, Toufik Homsi, Marie-Odile Réthoré, Jean Tredaniel

Tumori· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis